Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Neoplasma ; 67(1): 15-26, 2020 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-31607135

RESUMO

Glycogen synthase kinase beta (GSK3ß) is considered as a promising target for lung cancer treatment and its inhibitor lithium chloride (LiCl) is widely regarded as having potent anti-proliferative and apoptosis-modulating activities. Proliferating cell nuclear antigen (PCNA), as an auxiliary protein for DNA polymerase delta, which regulates DNA replication and repair, has been reported to play an important role in regulating apoptosis. Here, we showed that GSK3ß interacted with PCNA in H1299 lung adenocarcinoma cells using GST pull-down and co-immunoprecipitation experiments. We discovered that their interaction can be enhanced within the first 3 h after UVC irradiation and decreased gradually with time. Overexpression of PCNA protein decreased GSK3ß Ser9 phosphorylation, whereas knockdown of PCNA using small interfering RNA (siRNA) increased Ser9 phosphorylated GSK3ß, which was attenuated by phosphatidylinositol 3-kinase (PI3K) inhibitor LY294002 after UVC irradiation, indicating the involvement of the PI3K-AKT pathway. Functional analyses suggested that downregulation of PCNA sensitized H1299 cells to LiCl-induced apoptosis. Thus, our results unraveled a novel regulatory of GSK3ß by PCNA and provided a promising direction for treatment of lung cancer.


Assuntos
Adenocarcinoma de Pulmão/patologia , Apoptose , Glicogênio Sintase Quinase 3 beta/metabolismo , Antígeno Nuclear de Célula em Proliferação/metabolismo , Adenocarcinoma de Pulmão/metabolismo , Linhagem Celular Tumoral , Cromonas/farmacologia , Técnicas de Silenciamento de Genes , Humanos , Morfolinas/farmacologia , Fosfatidilinositol 3-Quinases/metabolismo , Fosforilação , Proteínas Proto-Oncogênicas c-akt/metabolismo , RNA Interferente Pequeno
2.
Transplant Proc ; 47(2): 323-31, 2015 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-25769567

RESUMO

INTRODUCTION: Chronic rejection (CR) is the leading cause of late renal transplant failure and is characterized by a relatively slow but progressive loss of renal function in combination with proteinuria and hypertension >3 months after transplantation. To identify and quantify the protein profiles in renal tissues of CR patients, we used isotope tagging for relative and absolute quantification (iTRAQ)-based proteomic technology to perform global protein expression analyses in CR patients and control subjects. MATERIALS AND METHODS: After protein extraction, quantitation, and digestion, samples were labeled with iTRAQ reagents and then separated by strong cation exchange and high-performance liquid chromatography. The fractions were further analyzed by tandem mass spectrometry. ProteinPilot version 4.0 software and the Swiss-Prot human database were applied for statistical analysis and database searching, respectively. Differentially expressed proteins were subjected to bioinformatic analysis by using the Gene Ontology database and the Kyoto Encyclopedia of Genes and Genomes database to further characterize their potential functional roles and related pathways in CR. RESULTS: In total, 1857 distinct proteins (confidence >95%, ρ < .05) were identified and quantified. Using a strict cutoff value of 1.5-fold for expressed variation, 87 proteins showed significant differences in expression between the CR and control groups; 53 were up-regulated and 34 were down-regulated. The differentially expressed proteins were mainly involved in protein binding, structural molecule activity, and extracellular matrix structural constituent. Several proteins, such as the alpha-1 chain of collagen type IV and integrin alpha-1, may play roles in the pathogenesis of CR and were implicated in the extracellular matrix-receptor interaction pathway. CONCLUSIONS: This study is the first to focus on iTRAQ-based quantitative proteomic characterization of renal tissue in CR. These insights may broaden our understanding of the molecular mechanisms underlying CR and provide potential biomarker candidates for future diagnostics.


Assuntos
Regulação para Baixo/fisiologia , Rejeição de Enxerto/metabolismo , Transplante de Rim , Proteínas/metabolismo , Proteômica/métodos , Regulação para Cima/fisiologia , Adulto , Biomarcadores/metabolismo , Biópsia , Estudos de Casos e Controles , Cromatografia Líquida de Alta Pressão , Doença Crônica , Feminino , Rejeição de Enxerto/etiologia , Humanos , Marcação por Isótopo , Nefropatias/metabolismo , Nefropatias/patologia , Nefropatias/cirurgia , Masculino , Pessoa de Meia-Idade , Espectrometria de Massas em Tandem
3.
Acta Derm Venereol ; 64(4): 361-3, 1984.
Artigo em Inglês | MEDLINE | ID: mdl-6209903

RESUMO

Treatment of large condylomata of the glans penis with a neodymium-YAG-laser is reported. The method offers certain advantages over more conventional means of therapy, but requires expensive equipment, experience and that precautionary measures be taken when the high-power laser is operated.


Assuntos
Condiloma Acuminado/cirurgia , Terapia a Laser , Neoplasias Penianas/cirurgia , Adulto , Humanos , Masculino , Neodímio , Pênis/cirurgia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...